AIDS Drug Assistance Programs | Drug Index | Patient Assistance Programs | Federal Poverty Guidelines | About The Access Project | ADAP Monitoring Project
Additional AIDS Drug Assistance Program (ADAP) information has been added to this page through the ADAP Monitoring Project. The March 2001 Report is available in pdf format. This project is a program of the National Alliance of State and Territorial AIDS Directors in association with the Access Project, supported by The Kaiser Family Foundation.
Note: American Samoa and Guam have Medicaid programs, but not ADAP.
The Access Project is an information clearinghouse. We collect and distribute information about medications available for HIV and AIDS through Medicaid, AIDS Drug Assistance Programs (ADAPs), and national pharmaceutical industry patient assistance/expanded access programs.
AIDS Drug Assistance Programs are listed by state. The Access Project has information and contact numbers for all 50 states and the territories. Information includes: point of contact, eligibility & pharmacies, medical criteria/dosages, care consortiums, which drugs are covered, and nutrition & vitamins. ADAP database: browse all states | search (updated 4/4/01)
- Drug Index: Descriptions of drugs, including side effects, dosages and managing side effects, for treatments included in ADAP programs. (updated 1/31/2002)
- Patient Assistance Programs: Programs that help people without government or private insurance afford necessary treatments. (updated 1/30/2002)
- Federal poverty guidelines: Federally defined income levels according to number of people in family. (updated 6/29/2000 to current levels)
- ADAP Monitoring Project, a program of the National Alliance of State and Territorial AIDS Directors in association with the Access Project, supported by The Kaiser Family Foundation. March 2001 Report
- New report available from the US General Accounting Office: HIV/AIDS Drugs: Funding Implications of New Combination Therapies for Federal and State Programs. HEHS-99-2. 25 pp. plus 4 appendices (11 pp.) October 14, 1998.
- General information about Medicaid: from the Health Care Financing Administration, the Medicaid/Medicare Agency.
We would like to hear from you. Did you find this site useful? Did you find the information you were looking for? Is there more you would like to see here? Send us a note at The AccessProject@aol.com or call (800) 734-7104.
The Access Project gratefully acknowledges support provided by unrestricted educational grants from private, corporate and foundation sources. For further information or to join our supporters please e-mail TheAccessProject@aol.com.
Merck & Co., Inc. is the principal sponsor of The Access Project. Their ongoing support has allowed us to inform ten thousands of people throughout the United States of their options, and to assist them to access needed treatments for AIDS and HIV-related conditions and symptoms, care and other resources. They have also supported our work to advocate for access to treatments by men, women and children throughout the United States. Roche has provided generous support to expand The Access Project to include an HIV/HCV initiative that will inform and assist people with HIV and HCV to access treatment and care for HCV. Roche is the principal sponsor of the HCV/HIV initiative. Pfizer, Inc. is the founding sponsor of The Access Project. Their support in the early years of the program enabled us to create this valuable resource, and make clinicians, providers and people with HIV/AIDS aware of its existence. The Henry J. Kaiser Family Foundation of Menlo Park, Ca has been a generous and enthusiastic supporter of The Access Project for several years. We are especially grateful for their support, vision, and integrity. (See recent ADAP Monitoring Project at http://www.kff.org/content/2001/20010329a/.) Generous supporters of The Access Project also include Agouron Pharmaceuticals and Bristol-Myers Squibb. The Robert D. Farber Foundation provided significant support to the project for several years, in honor and memory of our founding sponsor, Robert D. Farber.
We'd also like to thank the many Network supporters and members who have made small and large contributions to support this work.